Evidence map›Paper›PMID 24714505›Full record

ArticleJournal of pediatric hematology/oncology2014

Outcomes of pediatric low-grade gliomas treated with radiation therapy: a single-institution study.

Sunil S Raikar, Donna R Halloran, Michael Elliot, Michele McHugh, Shaun Patel, Karen M Gauvain

Abstract read
In one paragraph

Article in Journal of pediatric hematology/oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Treatment of Pediatric Low-Grade Gliomas.Current neurology and neuroscience reports · 2023
    Review
  5. Article
  6. Review
  7. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sunil S Raikar*Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University School of Medicine, Atlanta, GA †Department of Pediatrics, Saint Louis University School of Medicine ‡Division of Biostatistics, Saint Louis University School of Public Health §Department of Medicine, Division of Oncology ¶Department of Pediatrics, Division of Pediatric Hematology/Oncology, Washington University School of Medicine, Saint Louis, MO ∥Department of Medicine, Henry Ford Health System, Detroit, MI.
Donna R Halloran
Michael Elliot
Michele McHugh
Shaun Patel
Karen M Gauvain

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Burden of Late-Pre term Births throughout the First Year of LifeK08HD061484 · NICHD · SAINT LOUIS UNIVERSITY · PI HALLORAN, DONNA R. · 2010 to 2014
$652k
NCATS NIH HHS UL1 TR000448NICHD NIH HHS K08 HD061484
6 · The paper itself

Abstract

Radiation therapy is often considered the treatment of choice for low-grade gliomas. However, given the long-term effects of radiation on the developing brain, the appropriate use of radiation therapy in pediatric patients remains controversial. The purpose of this study was to evaluate progression-free survival (PFS) of pediatric low-grade glioma patients treated with radiation therapy. Data were obtained through a retrospective chart review of patients treated between 1991 and 2008 from a single tertiary care center in the midwest. The study population consisted of 17 patients, of whom 8 (47%) had tumor recurrence after radiation therapy. The median follow-up time was 8.2 years, with a range of 2.3 to 17.2 years. The median age at diagnosis was 5.4 years, and the median age at radiation therapy was 9.4 years. The 3- and the 10-year PFS were 69%± 11.7% and 46%± 13.3%, respectively. A significant difference in PFS was seen when comparing brainstem tumors with hypothalamic/optic pathway tumors (P=0.019). Differences in PFS based on the age at diagnosis, the extent of initial surgery, and indication for radiation therapy were not significant. A larger multicenter study is needed to better assess PFS in these patients.

Indexed as

AdolescentBrain NeoplasmsBrain Stem NeoplasmsChildChild, PreschoolCombined Modality TherapyDisease-Free SurvivalFemaleFollow-Up StudiesGliomaHumansHypothalamic NeoplasmsMaleNeoplasm GradingNeoplasm Recurrence, LocalRetrospective Studies

Identifiers

PMID24714505
PMCPMC4197833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.